OCD symptoms in succinic semialdehyde dehydrogenase (SSADH) deficiency: a case report. 2020

Sachin Phakey, and Thomas Rego, and Frank Gaillard, and Julie Panetta, and Andrew Evans, and Gerard De Jong, and Mark Walterfang
Neuropsychiatry Unit, Royal Melbourne Hospital, Grattan St, Parkville, VIC, 3050, Australia.

Succinic semialdehyde dehydrogenase (SSADH) deficiency is a rare neurometabolic disorder resulting in a heterogeneous clinical phenotype. Adolescent and adult patients with SSADH deficiency may present with OCD symptoms. There is minimal literature regarding the pathological basis of OCD symptoms and their management amongst SSADH deficiency patients. A 26-year-old woman with SSADH deficiency experienced obsessional slowness and hesitancy in her activities of daily living, with motor rituals and stereotypies of her hands and face. Neuroimaging revealed T2 hyperintensities of the globi pallidi bilaterally. Commencement of the serotonergic escitalopram moderately improved her OCD symptoms. The addition of the dopaminergic pramipexole hydrochloride yielded further improvement, following unsuccessful trial of other adjuncts: risperidone, methylphenidate and mirtazapine. Pallidal pathology may explain the manifestation of OCD symptoms amongst individuals with SSADH deficiency. Serotonergic and concomitant dopaminergic therapy may be a viable treatment regimen for SSADH deficiency patients presenting with OCD symptoms.

UI MeSH Term Description Entries
D009771 Obsessive-Compulsive Disorder An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension. Anankastic Personality,Neurosis, Obsessive-Compulsive,Anankastic Personalities,Disorder, Obsessive-Compulsive,Disorders, Obsessive-Compulsive,Neuroses, Obsessive-Compulsive,Neurosis, Obsessive Compulsive,Obsessive Compulsive Disorder,Obsessive-Compulsive Disorders,Obsessive-Compulsive Neuroses,Obsessive-Compulsive Neurosis,Personalities, Anankastic,Personality, Anankastic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002658 Developmental Disabilities Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed) Child Development Deviations,Child Development Disorders,Child Development Disorders, Specific,Developmental Delay Disorders,Disabilities, Developmental,Development Disorders, Child,Child Development Deviation,Child Development Disorder,Development Deviation, Child,Development Deviations, Child,Development Disorder, Child,Developmental Delay Disorder,Developmental Disability,Deviation, Child Development,Disability, Developmental
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000203 Activities of Daily Living The performance of the basic activities of self care, such as dressing, ambulation, or eating. ADL,Chronic Limitation of Activity,Limitation of Activity, Chronic,Activities, Daily Living,Activity, Daily Living,Daily Living Activities,Daily Living Activity,Living Activities, Daily,Living Activity, Daily
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000592 Amino Acid Metabolism, Inborn Errors Disorders affecting amino acid metabolism. The majority of these disorders are inherited and present in the neonatal period with metabolic disturbances (e.g., ACIDOSIS) and neurologic manifestations. They are present at birth, although they may not become symptomatic until later in life. Amino Acidopathies, Congenital,Amino Acid Metabolism Disorders, Inborn,Amino Acid Metabolism, Inborn Error,Amino Acid Metabolism, Inherited Disorders,Amino Acidopathies, Inborn,Congenital Amino Acidopathies,Inborn Errors, Amino Acid Metabolism,Inherited Errors of Amino Acid Metabolism,Amino Acidopathy, Congenital,Amino Acidopathy, Inborn,Congenital Amino Acidopathy,Inborn Amino Acidopathies,Inborn Amino Acidopathy
D050644 Succinate-Semialdehyde Dehydrogenase An enzyme that plays a role in the GLUTAMATE and butanoate metabolism pathways by catalyzing the oxidation of succinate semialdehyde to SUCCINATE using NAD+ as a coenzyme. Deficiency of this enzyme, causes 4-hydroxybutyricaciduria, a rare inborn error in the metabolism of the neurotransmitter 4-aminobutyric acid (GABA). NAD(+)-Dependent Succinic Semialdehyde Dehydrogenase,Succinate Semialdehyde Dehydrogenase,Succinic Semialdehyde Dehydrogenase,Dehydrogenase, Succinate Semialdehyde,Dehydrogenase, Succinate-Semialdehyde,Dehydrogenase, Succinic Semialdehyde,Semialdehyde Dehydrogenase, Succinate,Semialdehyde Dehydrogenase, Succinic

Related Publications

Sachin Phakey, and Thomas Rego, and Frank Gaillard, and Julie Panetta, and Andrew Evans, and Gerard De Jong, and Mark Walterfang
December 2009, Sleep,
Sachin Phakey, and Thomas Rego, and Frank Gaillard, and Julie Panetta, and Andrew Evans, and Gerard De Jong, and Mark Walterfang
January 2017, JIMD reports,
Sachin Phakey, and Thomas Rego, and Frank Gaillard, and Julie Panetta, and Andrew Evans, and Gerard De Jong, and Mark Walterfang
August 2006, Journal of inherited metabolic disease,
Sachin Phakey, and Thomas Rego, and Frank Gaillard, and Julie Panetta, and Andrew Evans, and Gerard De Jong, and Mark Walterfang
January 2004, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society,
Sachin Phakey, and Thomas Rego, and Frank Gaillard, and Julie Panetta, and Andrew Evans, and Gerard De Jong, and Mark Walterfang
January 2021, Current radiopharmaceuticals,
Sachin Phakey, and Thomas Rego, and Frank Gaillard, and Julie Panetta, and Andrew Evans, and Gerard De Jong, and Mark Walterfang
October 2003, Biological psychiatry,
Sachin Phakey, and Thomas Rego, and Frank Gaillard, and Julie Panetta, and Andrew Evans, and Gerard De Jong, and Mark Walterfang
September 2003, Zhonghua er ke za zhi = Chinese journal of pediatrics,
Sachin Phakey, and Thomas Rego, and Frank Gaillard, and Julie Panetta, and Andrew Evans, and Gerard De Jong, and Mark Walterfang
January 1985, Journal of inherited metabolic disease,
Sachin Phakey, and Thomas Rego, and Frank Gaillard, and Julie Panetta, and Andrew Evans, and Gerard De Jong, and Mark Walterfang
June 2004, Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology,
Sachin Phakey, and Thomas Rego, and Frank Gaillard, and Julie Panetta, and Andrew Evans, and Gerard De Jong, and Mark Walterfang
September 1984, Journal of neurogenetics,
Copied contents to your clipboard!